2001
DOI: 10.1073/pnas.051631398
|View full text |Cite
|
Sign up to set email alerts
|

DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
302
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 304 publications
(314 citation statements)
references
References 38 publications
4
302
0
1
Order By: Relevance
“…11 -13,15 However, its tissue distribution and cellular expression are not identical to DC-SIGN. 1,5,11,12,14,15 Notably, immunohistochemical and flow cytometric analyses have failed to detect …”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…11 -13,15 However, its tissue distribution and cellular expression are not identical to DC-SIGN. 1,5,11,12,14,15 Notably, immunohistochemical and flow cytometric analyses have failed to detect …”
Section: Discussionmentioning
confidence: 99%
“…Since other investigators were unable to detect DC-SIGNR expression on mucosal cells by immunohistochemistry 5 and, in the present study, we have observed much lower full-length than isoform mRNA copy numbers, we hypothesize that soluble isoforms are the most likely candidates to influence viral transmission. To address this, future studies must establish the presence of soluble DC-SIGNR protein in the tissue and determine the cellular source of DC-SIGNR in the mucosa, which most likely are endothelial 11,12,14 or certain infiltrating DCs, as indicated by our and other studies. 15,16 Most importantly, studies are required that compare the binding avidity for gp120 between DC-SIGNR isoforms generated from the 5-repeat allele and isoforms generated from the 7-repeat allele.…”
Section: Dc-sign(r) Mucosal Transcript Isoforms H Liu Et Almentioning
confidence: 98%
See 2 more Smart Citations
“…Several receptors have been reported to facilitate HIV-1 entry into CD4-negative cells. Specifically, galactosyl ceramide (34,35,95), adhesion molecules such as ICAM-1 and LFA-1 (27,28,72), C-type lectins such as DC-SIGN, DC-SIGNR, langerin, and the mannose receptor (12,30,66,87), and proteoglycans containing chondroitin or heparan sulfate proteoglycan chains (CSPGs or HSPGs, respectively) (8,15,53,75,94) have all been shown to promote HIV-1 attachment and/or entry into cells that lack CD4. To date, there is no demonstration that these receptors are capable of mediating fusion between viral and cellular membranes.…”
mentioning
confidence: 99%